Loteprednol Etabonate 0.25%

loteprednol etabonate · Bausch + Lomb

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Loteprednol Etabonate 0.25%, covering 2024-08-14 to 2024-08-14. Get the full timeline:

Most recent: Clinical Trial Update: Loteprednol Etabonate 0.25% for Prevention of Cornea Transplant Rejection [Phase 4]